Sacral root neuromodulation in the treatment of refractory urinary urge incontinence: a prospective randomized clinical trial
| Autor: | P. H. A. Eerdmans, R. A. Janknegt, J.L. Ruiz-Cerdá, Bart L.H. Bemelmans, E. H. J. Weil, P. Van Kerrebroeck |
|---|---|
| Rok vydání: | 2000 |
| Předmět: |
musculoskeletal diseases
Adult Male medicine.medical_specialty Randomization Time Factors Urology Lumbosacral Plexus Electric Stimulation Therapy law.invention Randomized controlled trial Refractory law Medicine Humans Prospective Studies Prospective cohort study Aged Cross-Over Studies business.industry Middle Aged musculoskeletal system Sacrum Neuromodulation (medicine) Surgery body regions Clinical trial Lumbosacral plexus Urinary Incontinence Female business Follow-Up Studies |
| Zdroj: | European urology. 37(2) |
| ISSN: | 0302-2838 |
| Popis: | To compare the effectiveness of sacral root neuromodulation with that of conservative management in ameliorating symptoms of refractory urinary urge incontinence and enhancing quality of life, to assess the objective response to neuromodulation as revealed by urodynamic testing, and to delineate the long-term outcomes of neuromodulation.Forty-four patients with refractory urge incontinence were randomized to undergo neuromodulation with an implantable impulse generator (n = 21) or to continue their prior conservative management (n = 23). At 6 months the control group was eligible for crossover to implant. Patient evaluation included voiding diaries, quality of life questionnaires, urodynamic testing, and documentation of adverse events. Long-term follow-up evaluations were conducted at 6-month intervals up to 36 months.At 6 months mean leakage episodes, leakage severity and pad usage in the implant group were significantly lower by 88% (p0.0005), 24% (p = 0.047) and 90% (p0.0005), respectively, than the corresponding control group mean values. Improvements in leakage episodes and pad usage of/=90% were attained by 75 and 85% of the implant group, respectively, but none of the control group. One third of implant patients, but none of the control patients, achieved/=50% improvement in leakage severity. Over half of the implant patients (56%) were completely dry compared with 1 control patient (4%). Implant patients, but not control patients, exhibited significant improvement with respect to two quality of life measures. Neuromodulation resulted in increases of 220% (p0.0005) and 39% (p = 0.013), respectively, in urodynamically assessed bladder volume at first contraction and maximum fill. At 36 months the actuarial rate of treatment failure was 32.4% (95% CI, 17.0-56.0%). Adverse events most frequently involved pain at the implant site, and the incidence of serious complications was low.Neuromodulation is markedly more effective than conservative management in alleviating symptoms of refractory urge incontinence. Quality of life and urodynamic function are also improved by neuromodulation. The effects of neuromodulation are long-lasting, and associated morbidity is low. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|